67 related articles for article (PubMed ID: 20963907)
1. [gamma-Seminoprotein (gamma-Sm)].
Miyahara S
Nihon Rinsho; 2010 Jul; 68 Suppl 7():743-6. PubMed ID: 20963907
[No Abstract] [Full Text] [Related]
2. [Gamma-seminoprotein (gamma-Sm)].
Miyahara S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():698-701. PubMed ID: 16149615
[No Abstract] [Full Text] [Related]
3. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of prostate specific antigen and gamma-seminoprotein ratio for diagnosing prostate cancer].
Akino H; Suzuki Y; Okada K
Nihon Rinsho; 1998 Aug; 56(8):2003-5. PubMed ID: 9750496
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
[TBL] [Abstract][Full Text] [Related]
6. [Prostate-specific antigen in cancer and benign prostatic hyperplasia].
Kushlinskiĭ NE; Liubimova NV; Gorilovskiĭ LM
Biull Eksp Biol Med; 1997 Sep; 124(9):327-30. PubMed ID: 9445619
[No Abstract] [Full Text] [Related]
7. Serum gamma-seminoprotein determination in prostatic cancer.
Shimazaki J; Akimoto S; Akakura K; Yoshiki T; Yoshida O; Okada K; Matsuoka K; Noda S; Eto K
Hinyokika Kiyo; 1991 Apr; 37(4):341-7. PubMed ID: 1716404
[TBL] [Abstract][Full Text] [Related]
8. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
Bratt O; Björk T
Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
[No Abstract] [Full Text] [Related]
9. [Specific quantification of gamma-seminoprotein-alpha 1 antichymotrypsin complex in serum by monoclonal antibody-based enzyme immunoassay].
Chichibu K; Kuroe K; Hashimoto C; Goto S
Rinsho Byori; 1995 Nov; 43(11):1153-8. PubMed ID: 8551680
[TBL] [Abstract][Full Text] [Related]
10. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
[TBL] [Abstract][Full Text] [Related]
11. [Benign prostatic hypertrophy with high levels of gamma-seminoprotein (gamma-Sm), prostate specific antigen: report of two cases].
Asakawa M; Yasumoto R; Kamizuru M; Maekawa M
Hinyokika Kiyo; 1988 Dec; 34(12):2189-91. PubMed ID: 2467544
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Miyao N; Ohmura K; Iwazawa M
Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917
[TBL] [Abstract][Full Text] [Related]
14. Re: Gamma-seminoprotein--a new tumour marker in prostatic cancer?
Scheit KH
Br J Urol; 1991 Sep; 68(3):331-2. PubMed ID: 1717099
[No Abstract] [Full Text] [Related]
15. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
[TBL] [Abstract][Full Text] [Related]
16. [Prostatic diseases: tumor markers (PAP and PSA) and age at risk].
Manna A; Trasatti L; Cifaldi L; Marchei GG; Reale MG; Marchei P
J Nucl Med Allied Sci; 1990; 34(4 Suppl):91. PubMed ID: 1709213
[No Abstract] [Full Text] [Related]
17. Ductal adenocarcinoma of the prostate.
Shazer RL; Luthringer D; Agus DB; Gross ME
Clin Adv Hematol Oncol; 2004 Jun; 2(6):393-5; discussion 396. PubMed ID: 16163211
[No Abstract] [Full Text] [Related]
18. [Gamma-Sm].
Miyahara S
Nihon Rinsho; 1999 Dec; 57 Suppl():523-5. PubMed ID: 10778180
[No Abstract] [Full Text] [Related]
19. [Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases].
Uchijima Y; Yoshida K; Saitoh H
Hinyokika Kiyo; 1991 Oct; 37(10):1255-60. PubMed ID: 1721770
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of tumor markers in prostatic cancer].
Ishihara Y; Fukagai T; Ohta K; Hiromoto Y; Hiramori M; Torii T; Higaki Y; Imamura K
Hinyokika Kiyo; 1990 Apr; 36(4):425-31. PubMed ID: 1696063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]